30 Day Trial


Founded in 1992, ORTHOWORLD® is the only provider of strategic intelligence in the world solely focused on the global orthopaedic market. Its singular mission is helping orthopaedic companies and individuals improve their performance.

Highly specialized product offerings such as ORTHOWORLD Membership, ORTHOFLASH®, market reports, BONEZONE® and OMTEC® empower industry participants to respond to challenges, maximize opportunities and more aggressively expand their orthopaedic businesses. We welcome the opportunity to assist you.


  • 12:30 p.m. Kinamed, developer of the CarboJet® CO2 bone prep system, announced a clinical study examining its use in traditional tourniquet vs. tourniquetless TKR.
  • 4:00 p.m. EDGe Surgical closed a US $4MM round of Series A financing to fund commercialization of both its single-use electronic depth gauge and future products.
  • PeekMed® received FDA 510(k) clearance to market its 3D pre-operative planning software.
Read More

Articles of Interest All Articles

FDA Priorities: People, Simplicity and a Risk-Based Approach to Speed Time to Market

By utilizing a more straightforward methodology, FDA can free up and better use resources to focus on high-risk areas that have the biggest impact. "Simplicity requires that FDA remain limber," writes John Gagliardi. "For industry to be innovative, the federal government must be innovative as well."